Office-use compounding in North Carolina

What the rule requires in practice

Each item carries a confidence level. Verbatim rule text is high confidence; a reading of how two provisions interact, or a source that could not be re-verified, is not.

The federal-law conditionHigh confidence

The rule does not create a federal safe harbour. It hands the question back to federal law, where § 353a conditions the compounding exemptions on a patient-specific prescription.The condition is in the rule’s own text. How it applies to a given supply arrangement is a legal question for your counsel.

Administer-only limitationHigh confidence

Explicit. The rule authorises supply "for those practitioners to administer" — it does not authorise the practitioner to dispense the compounded product for the patient to take home.

Quantity limitHigh confidence

None in the rule — no percentage cap, no day-supply cap, no per-practitioner cap.

Label legendHigh confidence

No "for office use only" statement required by .2801. Labelling defers to USP <795> and <797>, incorporated by reference including subsequent amendments and editions.

Anticipatory compoundingHigh confidence

Permitted under .2801(a)(2), but stock "shall not be dispensed until the pharmacy receives a valid prescription order for an individual patient."

Resale banHigh confidence

.2801(b) — "Compounded drug preparations shall not be offered to other entities for resale."

RecordkeepingHigh confidence

.2801(h) — the system must identify every compounded preparation prepared, labelled, or dispensed in the past three years, retrievable immediately on request.

Annual Board reportingHigh confidence

.2801(j) — between January 1 and March 31 each year, any Board-permitted pharmacy that compounded in the prior calendar year (for any patient or person, in or outside NC) must update its services information in NABP’s e-Profile Connect system.

Statutory layerHigh confidence

There is no "office use" provision anywhere in the NC Pharmacy Practice Act. Office use in North Carolina is rule-based only.Verified by searching the full statute compilation.

Last changeHigh confidence

Rule .2801 last amended effective August 1, 2021 — unchanged since.The Board’s current rulemaking docket (hearings March 17 and May 19, 2026, all effective Aug. 1, 2026) covers prescription transfers, alternate delivery sites, standardised orders, and influenza test-and-treat — nothing on compounding or office use.

North Carolina at a glance

Receiving 503B office stock in North Carolina

North Carolina permits the supply and then puts the credential somewhere almost nobody looks. The registration is issued by the Department of Agriculture, and the receiving side carries the heaviest dispensing trap of any state reviewed here.

Everything above this heading answers the supply question: may a state-licensed 503A pharmacy ship non-patient-specific stock? This section answers the other half. Registration with FDA under section 503B is a federal exemption from federal law and preempts no state licensing scheme, so it is never the whole answer on its own — a state credential is the norm rather than the exception, it is not always issued by the board of pharmacy, and in some states the category you would search for does not exist. What North Carolina asks for is set out below, including where we could not establish it.

What the 503B must hold to ship inHigh confidence

An Outsourcing Facility (Sterile 503B) registration with the N.C. Department of Agriculture & Consumer Services, $1,000 a year under G.S. 106-140.1(a) and (h). In-state and out-of-state facilities use the same category and the same fee; an out-of-state applicant also attaches home-state licence verification.Checking the Board of Pharmacy will find nothing — the word "outsourcing" appears zero times across all 6,285 lines of 21 NCAC 46. The nonresident pharmacy statute cannot reach a 503B either: G.S. 90-85.21A(a) applies to a pharmacy shipping a dispensed legend drug, and office stock is by definition not dispensed.

Does your practice need a permit?High confidence

None to administer. The only facility permits in 21 NCAC 46 are Pharmacy, Device & Medical Equipment and Limited Service; the Medical Board’s position-statement index carries nothing on compounded drugs, office use or in-office drug possession; and North Carolina does not license medical spas at all.

Administer vs dispenseHigh confidence

This is the North Carolina trap, and it lands on the building. 21 NCAC 46 .1703(c): "All drugs dispensed by a nurse practitioner or physician assistant must be dispensed from a place holding a current pharmacy permit from the Board." A clinic staffed by an NP or PA that sends patients home with vials needs a pharmacy permit at that location. A physician who dispenses for a fee registers separately, $75 a year..1703(d) adds that a pharmacist must be available for consultation whenever drugs are dispensed. Possession alone triggers neither.

Scheduled (controlled) stockMedium confidence

Genuinely unresolved — do not read it as clean. 10A NCAC 26E .0110(a) waives registration for individual practitioners "except as noted in G.S. 90-101(a1)", a caveat that has been a dead reference since 90-101(a1) was repealed in 2019. Yet NC-DCU still maintains a Clinic registration category, an application form and an unannounced inspection. Confirm with NC-DCU rather than assuming.

How to check a facility’s credential before you order is set out in how to place an office-use order.

What this page does not establish

• We have read the Board’s newsletters for January, April, July and October 2025 and for January and April 2026, but not the July 2026 issue. We think it unlikely that an office-use policy signal appeared there, and we have not read it to be sure.
• This page tracks the Board’s rule dockets and administrative history. It does not track the legislature, so a statutory change with no matching rule change would not appear here.